Abeona Therapeutics ABEO Income Statement (2010-2026)

NASDAQ ABEO
$5.95 +0.02 (+0.25%)
As of: Sep 4, 2026 · 2:21 PM EDT
Reported Financials

Abeona Therapeutics Quarterly Income Statement

Periods 63 quarters
Latest Jun 2026

Abeona Therapeutics reported revenue of $11.38M and net income of -$20.25M for the quarter ended Jun 2026. This income statement covers 63 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & Cost
Revenue
0.35M1.00M0.07M3.50M0.40M5.42M8.72M11.38M
Interest income
Interest Income - Total
0.01M0.01M0.01M0.03M0.07M0.33M0.36M0.42M0.59M0.74M0.84M1.19M1.19M1.02M1.31M1.03M1.67M1.55M1.35M1.35M
Interest expenses
Interest Expense - Others
0.20M
Interest ExpensesInterest Expense
0.68M0.05M0.20M0.20M0.16M0.18M0.10M0.10M0.10M0.11M0.95M1.07M1.10M1.08M1.00M0.96M0.90M0.88M0.83M0.70M
Interest Income - Net
-0.68M-0.05M-0.19M-0.17M-0.09M0.15M0.26M0.31M0.49M0.63M-0.11M0.12M0.09M-0.06M0.31M0.07M0.77M0.66M0.52M0.66M
Operating Items
Depreciation & Amortization - TotalDep. & Amort. (Tot)
Research & DevelopmentR&D
9.06M12.80M10.54M6.66M5.49M6.27M8.04M8.52M7.15M7.38M7.21M9.22M8.94M8.99M9.94M5.94M4.22M6.71M9.55M5.02M
Selling, General & AdministrativeSG&A
5.82M4.38M4.22M3.46M3.89M5.68M4.00M5.02M4.16M5.83M7.12M8.65M6.40M7.68M9.79M17.15M19.31M18.78M19.50M15.84M
Other Operating ExpensesOther Opex
0.00M32.47M-0.01M-1.11M-0.02M1.05M0.40M0.51M0.03M0.10M0.49M2.84M2.70M4.18M
Operating ExpensesOpex
14.87M49.65M20.94M9.01M9.38M13.00M12.04M14.05M11.33M13.21M14.33M17.86M15.35M16.67M19.73M23.19M24.02M28.33M31.75M25.03M
Operating IncomeOp. Inc
-14.87M-46.65M-20.59M-8.01M-9.38M-12.94M-12.04M-10.55M-11.33M-13.21M-14.33M-17.86M-15.35M-16.67M-19.73M-22.79M-24.02M-22.91M-23.03M-13.65M
EBIT
-14.87M-46.65M-20.59M-8.01M-9.38M-12.94M-12.04M-10.55M-11.33M-13.21M-14.33M-17.86M-15.35M-16.67M-19.73M-22.79M-24.02M-22.91M-23.03M-13.65M
Non-operating items
Non Operating Interest Expenses
0.68M0.05M0.20M0.20M0.16M0.18M0.10M0.10M0.10M0.11M0.95M1.07M1.10M1.08M1.00M0.96M0.90M0.88M0.83M0.70M
Interest & Investment IncomeInt & Inv Inc
0.03M
Other Non Operating IncomeOther Non Op Inc.
Non Operating IncomeNon Op. Inc.
-0.12M-0.02M0.28M0.40M2.21M0.11M0.21M0.16M0.22M0.14M0.66M0.14M0.09M0.13M0.05M0.05M-0.01M
Net income details
EBT
-15.55M-46.70M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M-9.29M-12.03M124.34M-20.36M-20.68M-17.07M-20.19M
Tax ProvisionsTaxes
-13.38M15.20M14.65M0.00M
Profit After TaxPAT
-7.05M-46.70M-22.05M-7.88M-6.44M-7.21M-9.11M-16.68M-11.84M-16.59M-31.70M-13.45M-30.27M-9.28M-12.10M113.67M-5.16M-20.33M-17.23M-20.25M
Income from Continuing OperationsIncome (Continuing)
-15.55M-46.70M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M4.09M-12.03M124.34M-35.56M-35.33M-17.07M-20.19M
Consolidated Net IncomeConsol Net Inc.
-15.55M-46.70M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M4.09M-12.03M124.34M-35.56M-35.33M-17.07M-20.19M
Income towards Parent CompanyParent Net Inc
-15.55M-46.70M-20.79M-8.18M-9.54M-13.11M-12.14M-10.66M-11.44M-13.32M-15.28M7.41M-30.27M4.09M-12.03M124.34M-35.56M-35.33M-17.07M-20.19M
Preferred Dividend PaymentsPref Dividends
3.78M
Net Income towards Common StockholdersNet Income
-7.04M-46.68M-20.79M-7.88M-6.43M-7.10M-9.10M-16.65M-11.84M-16.60M-31.60M7.40M-30.20M-9.30M-12.00M124.34M-35.56M-35.33M-17.07M-20.19M
Additional items
EPS (Basic)
-0.07-0.47-0.14-1.36-1.00-0.90-0.54-0.92-0.48-0.78-1.160.18-0.63-0.23-0.242.37-0.66-0.67-0.30-0.35
EPS (Diluted)
-3.63-24.03-10.70-1.36-1.00-0.90-0.54-0.92-0.48-0.78-1.160.14-0.63-0.23-0.241.87-0.66-0.53-0.30-0.35
Shares Outstanding
97.99M98.44M144.88M5.81M6.42M7.86M16.90M18.02M24.80M21.38M27.32M40.01M48.08M41.05M49.78M52.52M54.24M52.95M56.62M57.05M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
1.94M1.94M1.94M5.81M6.42M7.86M16.90M18.02M24.80M21.38M27.32M51.23M48.08M41.05M49.78M66.64M54.24M66.14M56.62M57.05M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
101.87M98.44M147.08M5.87M7.67M7.86M17.93M21.48M24.71M21.38M27.55M41.66M43.40M45.64M48.95M51.25M52.40M55.04M56.87M57.23M
EBITDA
-14.87M-46.65M-20.59M-8.01M-9.38M-12.94M-12.04M-10.55M-11.33M-13.21M-14.33M-17.86M-15.35M-16.67M-19.73M-22.79M-24.02M-22.91M-23.03M-13.65M